at this dose, tirzeaptide drives ~8.3% weight loss compared to 6.6% for semaglutide over 40 weeks in the head-to-head SURPASS-2 trial in patients with obesity and T2D
Pillar 1: Reninangiotensin aldosterone system blockade The evidence for RAAS blockade in DKD treatment has been established for over 30 years
31 In a trial evaluating semaglutide for weight loss, the incidence of acute pancreatitis was still low (3 of 1,306 participants) despite a higher dose and more significant weight loss, but none of the 655 individuals in the placebo group developed pancreatitis
627 in RA patients, decreased butyrate levels may lead to Tfr suppression and synovial inflammation
These effects may help: Reduce appetite Increase satiety Support healthier eating habits Improve blood sugar regulation Encourage long-term weight loss Its ability to affect multiple pathways simultaneously is one reason researchers have been excited about its potential role in weight management
Sanya Juneja, Ankit Bayala, and Aanchal Singhania also contributed to this article.
